Lenacapavir

Zimbabwe becomes among the first countries globally to launch lenacapavir, a twice-yearly injectable HIV prevention drug, while health organizations across Africa push for emergency health education integration into school curricula.

Zimbabwe will launch Lenacapavir, a six-month HIV prevention injection, targeting 46,000 high-risk individuals in Epworth on 18 February, while the Red Cross prepares 100 volunteers for potential cholera outbreak response in Harare.